Jonathan Montagu

Non Executive Director at OMass Technologies

Jonathan Montagu has a strong background in the biotechnology industry, with significant experience in leadership roles. Jonathan is currently serving as the President & Chief Executive Officer at HotSpot Therapeutics, Inc. In this role, they oversee the company's operations and strategic direction.

Prior to their current position, Montagu held various other roles in the biotech sector. Jonathan served as a Non Executive Director at OMass Therapeutics, where they provided guidance and expertise to the company. Jonathan also worked as an Entrepreneur-in-Residence at Atlas Venture, where they supported the development of innovative biotech startups.

Montagu has also held executive positions at Epiios Therapeutics and Nimbus Therapeutics. At Epiios, they served as Chief Executive Officer and played a key role in developing next-generation biologics for cancer and liver disease. At Nimbus Therapeutics, they served as Chief Business Officer and was instrumental in advancing a diverse pipeline of small molecule product candidates.

Before entering the biotech industry, Montagu gained experience in business development and consulting roles. Jonathan worked as a Senior Director of Business Development at Concert Pharmaceuticals and as a New Product Development Manager at Ortho-McNeil Pharmaceuticals. Jonathan also had an internship in business development at Biogen Idec.

Montagu's early career includes experience as a Special Advisor at Chiron Corporation and as a Consultant at Boston Consulting Group.

Overall, Jonathan Montagu has a strong track record of leadership and expertise in the biotechnology industry, with a focus on developing innovative therapies and driving strategic growth.

Jonathan Montagu obtained a Masters degree in Chemistry from the University of Oxford, where they studied from 1994 to 1999. Following this, they pursued a Master of Business Administration (MBA) from Stanford University from 2003 to 2005. Jonathan's educational focus shifted from Chemistry to Business Administration during their academic journey.

Links

Previous companies

Concert Pharmaceuticals logo
Nimbus Therapeutics logo

Timeline

  • Non Executive Director

    May, 2019 - present